Transient acantholytic dyskeratosis (Grover's disease) after bone marrow transplantation.
Penny Poh Lu LimPablo Fernandez-PenasDavid GottliebPublished in: The Australasian journal of dermatology (2016)
Cutaneous eruptions in recipients of allogeneic haematopoietic stem cell transplantation (AHSCT) are frequent, and common aetiologies include graft-versus-host disease (GVHD), drug reactions, viral infections and engraftment syndrome. Transient acantholytic dermatosis or Grover's disease has been described in oncology patients and it is rarely reported after AHSCT. However, this benign and self-limiting condition should be histologically distinguished from other, more serious entities, mainly stage IV GVHD, in order to avoid inappropriate treatment with corticosteroids and intensive immunosuppression.
Keyphrases
- stem cell transplantation
- bone marrow
- high dose
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- mesenchymal stem cells
- allogeneic hematopoietic stem cell transplantation
- prognostic factors
- sars cov
- cerebral ischemia
- peritoneal dialysis
- patient reported outcomes
- case report
- acute lymphoblastic leukemia
- acute myeloid leukemia
- combination therapy
- electronic health record
- adverse drug